These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 20082876
1. Influence of genetic polymorphism in matrix metalloproteinase-3 on extent of coronary atherosclerosis and risk of coronary artery stenosis. Seifi M, Fallah S, Firoozrai M. Arch Med Res; 2009 Oct; 40(7):600-4. PubMed ID: 20082876 [Abstract] [Full Text] [Related]
2. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer]. Fang SM, Jin X, Li Y, Wang R, Guo W, Wang N, Zhang JH. Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531 [Abstract] [Full Text] [Related]
3. Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome. Liu PY, Li YH, Chan SH, Lin LJ, Wu HL, Shi GY, Chen JH. Am J Cardiol; 2006 Oct 15; 98(8):1012-7. PubMed ID: 17027562 [Abstract] [Full Text] [Related]
4. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis]. Kang S, Wang Y, Zhang JH, Jin X, Fang SM, Li Y. Zhonghua Fu Chan Ke Za Zhi; 2005 Sep 15; 40(9):601-4. PubMed ID: 16202315 [Abstract] [Full Text] [Related]
5. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Köppel H, Leithner A, Wascher TC, Paulweber B, Samonigg H. Clin Cancer Res; 2004 May 15; 10(10):3518-20. PubMed ID: 15161710 [Abstract] [Full Text] [Related]
7. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Zhang J, Jin X, Fang S, Li Y, Wang R, Guo W, Wang N, Wang Y, Wen D, Wei L, Kuang G, Dong Z. Carcinogenesis; 2004 Dec 15; 25(12):2519-24. PubMed ID: 15319302 [Abstract] [Full Text] [Related]
8. The association of the metalloproteinase-3 gene promoter polymorphisms and the middle cerebral artery stenosis. Fu C, Xing Y, Song X. Cell Biochem Biophys; 2011 Apr 15; 59(3):185-9. PubMed ID: 21113741 [Abstract] [Full Text] [Related]
9. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients. Ozkök E, Aydin M, Babalik E, Ozbek Z, Ince N, Kara I. Med Sci Monit; 2008 Oct 15; 14(10):CR536-42. PubMed ID: 18830194 [Abstract] [Full Text] [Related]
10. [Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease]. Gao B, Li ZC. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep 15; 16(9):536-9. PubMed ID: 15355616 [Abstract] [Full Text] [Related]
11. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma]. Lu ZQ, Wang YM, Cao YY, Zhang QJ, Zhang XH, Li YH, Wang HS, Xie HL, Jiao BH, Zhang JH. Ai Zheng; 2007 May 15; 26(5):463-8. PubMed ID: 17672933 [Abstract] [Full Text] [Related]
12. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Humphries S, Bauters C, Meirhaeghe A, Luong L, Bertrand M, Amouyel P. Eur Heart J; 2002 May 15; 23(9):721-5. PubMed ID: 11977998 [Abstract] [Full Text] [Related]
13. Risk of coronary artery stenosis in Iranian type 2 diabetics: is there a role for matrix metalloproteinase-3 gene (-1612 5A/6A) polymorphism? Fallah S, Seifi M, Samadikuchaksaraei A. J Physiol Biochem; 2010 Dec 15; 66(4):359-64. PubMed ID: 20740392 [Abstract] [Full Text] [Related]
14. Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis. Djurić T, Zivković M, Radak D, Jekić D, Radak S, Stojković L, Raicević R, Stanković A, Alavantić D. Clin Biochem; 2008 Nov 15; 41(16-17):1326-9. PubMed ID: 18801353 [Abstract] [Full Text] [Related]
15. Do schizophrenia and bipolar disorders share a common disease susceptibility variant at the MMP3 gene? Kucukali CI, Aydin M, Ozkok E, Bilge E, Orhan N, Zengin A, Kara I. Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr 30; 33(3):557-61. PubMed ID: 19245826 [Abstract] [Full Text] [Related]
16. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population. Astolfi CM, Shinohara AL, da Silva RA, Santos MC, Line SR, de Souza AP. J Clin Periodontol; 2006 Oct 30; 33(10):699-703. PubMed ID: 16899023 [Abstract] [Full Text] [Related]
17. The functional (-1171 5A-->6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users. Tu HF, Liu CJ, Chang CS, Lui MT, Kao SY, Chang CP, Liu TY. J Oral Pathol Med; 2006 Feb 30; 35(2):99-103. PubMed ID: 16430740 [Abstract] [Full Text] [Related]
18. Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population. Tang LJ, Chen XF, Zhu M, Jiang JJ, Lu XB, Du YX, Wang B, Fang CF, Xue YS, Shen WF. Clin Biochem; 2007 Dec 30; 40(18):1427-30. PubMed ID: 18028894 [Abstract] [Full Text] [Related]
19. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Fang S, Jin X, Wang R, Li Y, Guo W, Wang N, Wang Y, Wen D, Wei L, Zhang J. Carcinogenesis; 2005 Feb 30; 26(2):481-6. PubMed ID: 15528217 [Abstract] [Full Text] [Related]
20. The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer. Szyllo K, Smolarz B, Romanowicz-Makowska H, Niewiadomski M, Kozlowska E, Kulig A. J Exp Clin Cancer Res; 2002 Sep 30; 21(3):357-61. PubMed ID: 12385578 [Abstract] [Full Text] [Related] Page: [Next] [New Search]